Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-09

Clinical Trial Update: Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing extended pelvic lymph node dissection versus no pelvic lymph node dissection during radical prostatectomy in intermediate- and high-ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED